AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The role of Activation-Induced Cytidine Deaminase (AID) in somatic hypermutation and polyclonal antibody affinity maturation has not been shown for polyclonal responses in humans. We investigated whether AID induction in human B cells following H1N1pdm09 vaccination correlated with in-vivo antibody affinity maturation against hemagglutinin domains in plasma of young and elderly individuals. AID was measured by qPCR in B cells from individuals of different ages immunized with the H1N1pdm09 influenza vaccine. Polyclonal antibody affinity in human plasma for the HA1 and HA2 domains of the H1N1pdm09 hemagglutinin was measured by antibody-antigen complex dissociation rates using real time kinetics in Surface Plasmon Resonance. Results show an age-related decrease in AID induction in B cells following H1N1pdm09 vaccination. Levels of AID mRNA before vaccination and fold-increase of AID mRNA expression after H1N1pdm09 vaccination directly correlated with increase in polyclonal antibody affinity to the HA1 globular domain (but not to the conserved HA2 stalk). In the younger population, significant affinity maturation to the HA1 globular domain was observed, which associated with initial levels of AID and fold-increase in AID after vaccination. In some older individuals (>65 yr), higher affinity to the HA1 domain was observed before vaccination and H1N1pdm09 vaccination resulted in minimal change in antibody affinity, which correlated with low AID induction in this age group. These findings demonstrate for the first time a strong correlation between AID induction and in-vivo antibody affinity maturation in humans. The ability to generate high affinity antibodies could have significant impact on the elucidation of age-specific antibody responses following vaccination and eventual clinical efficacy and disease outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Antibody affinity maturation, measured by the antigen-antibody complex dissociation rate, increases for HA1 domain (but not HA2) following immunization with H1N1pdm09 subunit vaccine. (A) SPR analysis of pre- (open circles) and post- (filled circles) H1N1pdm09-vaccinated human plasma from all study participants (20–90 yrs old). Binding assays were conducted with functional H1N1pdm09 HA1 (1–330) or HA2 stalk domains [34]. Polyclonal human plasma antibody off-rate constants were determined as previously described [9]. (B) Correlation between increase in polyclonal plasma antibody affinity to HA1 domain (measured by a fold decrease of the antigen-antibody complex dissociation-rate) following H1N1pdm09 vaccination compared with the pre-vaccination off-rates against HA1. (C, D) Fold-increase in human plasma antibody affinity (decrease in antibody off-rate) after vaccination against the globular HA1 domain (C) or HA2 stalk domain (D) compared with the age of the vaccinated individuals. Post-H1N1pdm09 vaccination increase in polyclonal antibody affinity to the HA1 domain (but not HA2) was inversely correlated with subjects' age.](https://figures.cochat.ai/paper-figures/3e67521bf44240fbaebe2adf7efed426/aid-activity-in-b-cells-strongly-correlates-with-polyclonal-antibody-affinity-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, the serum antibody response to both seasonal and pandemic influenza vaccines, as well as the in vitro B-cell response after vaccination, are both decreased with increasing age and are significantly correlated [114, 124, 125].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [124]
Experimental — accuracy not yet measuredIn the citing paper
“AID is a measure of optimal B-cell responses and its decreased expression in B cells from elderly individuals has been shown to lead to a reduced ability to generate higher affinity protective antibodies [124].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Khurana, S., Verma, S., Verma, N., Crevar, C. J., Carter, D. M., Manischewitz, J., King, L. R., Ross, T. M., & Golding, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011548 · Cited by 96 · cited 2×
“The fraction of antigen-antibody complexes decaying per second were determined directly from plasma sample interaction with properly folded, H1N1pdm09 functional HA1 globular domain and HA2 stalk domain proteins [34] during the dissociation phase.”
BackgroundMethodSelf-citationRetractedMuramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474 · cited 1×
“response to antigenic stimulation and T cell signals [1–2].”
BackgroundEmergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037 · cited 1×
“However, in spite of low AID activity and minimal change in and HI titers, post-H1N1pdm09 vaccination, older adults were relatively protected from the pandemic H1N1 compared with younger adults probably due to the presence of affinity mature B cells and polyclonal antibody responses [26,27,28,29,30].”
BackgroundHospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,001 · cited 1×
“However, in spite of low AID activity and minimal change in and HI titers, post-H1N1pdm09 vaccination, older adults were relatively protected from the pandemic H1N1 compared with younger adults probably due to the presence of affinity mature B cells and polyclonal antibody responses [26,27,28,29,30].”
BackgroundGerminal-Center Organization and Cellular Dynamics
Allen, C. D. C., Okada, T., & Cyster, J. G. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.009 · Cited by 983
Imaging of Germinal Center Selection Events During Affinity Maturation
Allen, C. D. C., Okada, T., Tang, H. L., & Cyster, J. G. (2007) · Science · doi:10.1126/science.1136736 · Cited by 779 · cited 1×
“(TFH) [17–18] [19,20].”
Good-Jacobson, K. L., Szumilas, C. G., Chen, L., Sharpe, A. H., Tomayko, M. M., & Shlomchik, M. J. (2010) · Nature Immunology · doi:10.1038/ni.1877 · Cited by 691 · cited 1×
“(TFH) [17–18] [19,20].”
Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza
Chowell, G., Bertozzi, S. M., Colchero, M. A., Lopez-Gatell, H., Alpuche-Aranda, C., Hernandez, M., & Miller, M. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904023 · Cited by 684 · cited 1×
“However, in spite of low AID activity and minimal change in and HI titers, post-H1N1pdm09 vaccination, older adults were relatively protected from the pandemic H1N1 compared with younger adults probably due to the presence of affinity mature B cells and polyclonal antibody responses [26,27,28,29,30].”
BackgroundFrom Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Cited by
Understanding immunosenescence to improve responses to vaccines
Goronzy, J. J., & Weyand, C. M. (2013) · Nature Immunology · doi:10.1038/ni.2588 · Cited by 827
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Aging of the immune system: Focus on inflammation and vaccination
Pinti, M., Appay, V., Campisi, J., Frasca, D., Fülöp, T., Sauce, D., Larbi, A., Weinberger, B., & Cossarizza, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201546178 · Cited by 439
Self-citationAging and the immune system: An overview
Sadighi Akha, A. A. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.08.005 · Cited by 388
Inflammaging decreases adaptive and innate immune responses in mice and humans
Frasca, D., & Blomberg, B. B. (2016) · Biogerontology · doi:10.1007/s10522-015-9578-8 · Cited by 357
“Our published results have shown that the specific response of B cells to vaccination in vivo and in vitro are both decreased with age and are significantly correlated (Frasca et al. 2010, 2012a; Khurana et al. 2012).”
Self-citationFrasca, D., Diaz, A., Romero, M., Garcia, D., & Blomberg, B. B. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011620-034148 · Cited by 225
Self-citationKeating, R., Hertz, T., Wehenkel, M., Harris, T. L., Edwards, B. A., McClaren, J. L., Brown, S. A., Surman, S., Wilson, Z. S., Bradley, P., et al. (2013) · Nature Immunology · doi:10.1038/ni.2741 · Cited by 193
AS03- and MF59-Adjuvanted Influenza Vaccines in Children
Wilkins, A. L., Kazmin, D. A., Napolitani, G., Clutterbuck, E., Pulendran, B., Siegrist, C., & Pollard, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01760 · Cited by 167
“The cross-reactive antibodies undergo affinity maturation following immunization (H1N1-pdm09), which correlates with increased expression of activation-induced cytidine deaminase (72).”
BackgroundUnderstanding immunosenescence and its impact on vaccination of older adults
Allen, J. C., Toapanta, F. R., Chen, W. H., & Tennant, S. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.002 · Cited by 173
“Indeed, aged mice demonstrate AID-associated impaired CSR and decreased effector antibody isotypes [72], and it has been shown that a decline in AID mRNA in human B cells correlates with decreased antibody affinity maturation following influenza vaccination [73].”
BackgroundFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.023 · Cited by 144
“Although we [9-11] and others [12-14] have shown that aging significantly impairs the antibody response to Influenza A(H1N1)pdm09 virus [9, 10], elderly individuals respond with protective titers with repeated immunization [9, 11], as we also show in this paper.”
Self-citationAging and influenza vaccine-induced immunity
Dugan, H. L., Henry, C., & Wilson, P. C. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103998 · Cited by 142
Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination
Frasca, D., & Blomberg, B. B. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00210-z · Cited by 130
Self-citationDhakal, S., & Klein, S. L. (2019) · Journal of Virology · doi:10.1128/jvi.00797-19 · Cited by 134
“Reduced influenza-specific activation-induced cytidine deaminase (AID) responses and the percentage of switch memory B cells (35, 36), reduced affinity maturation (37), lower number of antibody-secreting cells or plasmablasts (38), impaired memory B cell to plasma cell differentiation (39), diminished antibody diversi…”
BackgroundCytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine
Frasca, D., Diaz, A., Romero, M., Landin, A. M., & Blomberg, B. B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.071 · Cited by 116
“The enzyme AID is another B cell-specific biomarkers which we have shown can be used to predict the in vivo response to the influenza vaccine, because it completely correlates with the ability of human B cells to undergo CSR [14, 17] and affinity maturation [18] of Ig genes.”
Self-citationHou, Y., Chen, M., Bian, Y., Hu, Y., Chuan, J., Zhong, L., Zhu, Y., & Tong, R. (2024) · npj Vaccines · doi:10.1038/s41541-024-00874-4 · Cited by 140
“Moreover, research has shown that the expression of activation-induced cytidine deaminase necessary for af fi nity maturation and class switching in B cells is signi fi cantly reduced in elderly individuals 39 , which subsequently leads to decreased af fi nity and antibody responses.”
BackgroundHigh TNF-α levels in resting B cells negatively correlate with their response
Frasca, D., Diaz, A., Romero, M., Landin, A. M., & Blomberg, B. B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.004 · Cited by 115
“1B) show that aging significantly decreases the in vivo vaccine-specific response of elderly as compared to young individuals, as we (Frasca et al., 2010, 2012a; Khurana et al., 2012) and others (Deans et al.”
Self-citationBulati, M., Caruso, C., & Colonna‐Romano, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.04.001 · Cited by 121
“As AID is considered a measure of optimal B cell responses, its decreased expression on B cells from elderly individuals, explains, in part, their reduced ability to generate higher affinity protective antibodies (Frasca and Blomberg, 2014, 2016; Khurana et al., 2012).”
BackgroundBasic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers
Lagathu, C., Cossarizza, A., Béréziat, V., Nasi, M., Capeau, J., & Pinti, M. (2017) · AIDS · doi:10.1097/qad.0000000000001441 · Cited by 110
“Copyright © 2017 Wolters Kluwe induced cytidine deaminase is lower [157] and somatic hypermutation and class switch recombination are impaired [158,159].”
BackgroundA comparative review of aging and B cell function in mice and humans
Scholz, J. L., Diaz, A., Riley, R. L., Cancro, M. P., & Frasca, D. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.006 · Cited by 104
“Reduced affinity maturation of the antibodies generated in response to an influenza vaccine has recently been reported in humans [55].”
BackgroundSelf-citationFighting against a protean enemy: immunosenescence, vaccines, and healthy aging
Del Giudice, G., Goronzy, J. J., Grubeck-Loebenstein, B., Lambert, P.-H., Mrkvan, T., Stoddard, J. J., & Doherty, T. M. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0020-0 · Cited by 91
“Reduced isotype switching efficiency in older adults is associated with reduced expression of activation-induced cytidine deaminase (AID), which has been proposed as a potential biomarker predicting the response to antigens following vaccination in both young and older adults.(32) The level of switched memory B cells…”
BackgroundFrasca, D., Diaz, A., Romero, M., Mendez, N. V., Landin, A. M., Ryan, J. G., & Blomberg, B. B. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.003 · Cited by 79
Self-citationFrasca, D., Diaz, A., Romero, M., Mendez, N. V., Landin, A. M., & Blomberg, B. B. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-14 · Cited by 77
“We previously reported that individuals of this age may be categorized in the “elderly/affected” group [34,35,38,39], as B cell numbers and functions (antibody production and affinity maturation) are significantly decreased.”
BackgroundSelf-citationThe impact of age-related syndromes on ICU process and outcomes in very old patients
Vallet, H., Guidet, B., Boumendil, A., de Lange, D. W., Leaver, S. K., Szczeklik, W., Jung, C., Sviri, S., Beil, M., & Flaatten, H. K. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01160-7 · Cited by 88
“The consequences are a decrease of antibody production [20] and an impaired production of higher affinity protective antibody [21].”
BackgroundImpact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection
Merani, S., Pawelec, G., Kuchel, G. A., & McElhaney, J. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00784 · Cited by 74
Cakala, M., Kołodziej, P., & Puzianowska‐Kuźnicka, M. (2021) · Cells · doi:10.3390/cells10113148 · Cited by 89
Diaz, A., Romero, M., Vazquez, T., Lechner, S. C., Blomberg, B. B., & Frasca, D. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.078 · Cited by 77
“The expression of AID in response to CpG is a measure of the quality of the B cell response, and we have shown that it can also predict the in vivo antibody response to the influenza vaccine [20,22,25,37].”
BackgroundMethodSelf-citationMicroRNAs miR-155 and miR-16 decrease AID and E47 in B cells from elderly individuals
Frasca, D., Diaz, A., Romero, M., Ferracci, F., & Blomberg, B. B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500520 · Cited by 69
“We have previously shown for the markers we measure, for example, AID, that those aged $60 y have similar decreased characteristics (25).”
BackgroundSelf-citationAdipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging
Frasca, D., & Blomberg, B. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01003 · Cited by 66
“Because AID correlates with optimal B cell function, it can be used as a predictive marker of optimal B cell response in humans (16, 17).”
BackgroundInfluentialSelf-citationJegaskanda, S., Laurie, K. L., Amarasena, T. H., Winnall, W. R., Kramski, M., De Rose, R., Barr, I. G., Brooks, A. G., Reading, P. C., & Kent, S. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit294 · Cited by 64
“Antibodies frequently target regions outside the receptorbinding domain of HA, and elderly individuals have a greater antibody diversity and higher affinity for the HA1 region of A (H1N1)pdm09 HA, compared with younger individuals [37, 38].”
BackgroundElrashdy, F., Redwan, E. M. M. M., & Uversky, V. N. (2020) · Biomolecules · doi:10.3390/biom10091312 · Cited by 72
T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection
Pallikkuth, S., de Armas, L. R., Rinaldi, S., & Pahwa, S. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01380 · Cited by 68
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
Budroni, S., Buricchi, F., Cavallone, A., Bourguignon, P., Caubet, M., Dewar, V., D’Oro, U., Finco, O., Garçon, N., Idrissi, M. E., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00337-0 · Cited by 69
How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions
Chen, J., Deng, J. C., & Goldstein, D. R. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.09.008 · Cited by 64
B cell function and influenza vaccine responses in healthy aging and disease
Frasca, D., & Blomberg, B. B. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.05.008 · Cited by 59
“Our results have shown that the specific response of B cells to vaccination in vivo and in vitro are both decreased with age and are significantly correlated [36 ,37,38 ].”
BackgroundResultInfluentialSelf-citationFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616650 · Cited by 58
Self-citationParadoxical aging in HIV: immune senescence of B Cells is most prominent in young age
Rinaldi, S., Pallikkuth, S., George, V. K., de Armas, L. R., Pahwa, R., Sanchez, C. M., Pallin, M. F., Pan, L., Cotugno, N., Dickinson, G., et al. (2017) · Aging · doi:10.18632/aging.101229 · Cited by 56
“This subset has been shown to be reduced and functionally impaired in old healthy individuals [9, 12] and to be important for the B cellular response to influenza in HC and HIV [13, 14, 16].”
BackgroundResultConsiderations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population
Stephens, L. M., & Varga, S. M. (2021) · Vaccines · doi:10.3390/vaccines9060624 · Cited by 55
“Somatic hypermutation and class-switch recombination, which are essential for the generation of isotype-switched antibody responses against encountered pathogens as well as vaccinations, are also impaired in aged mice [71,72].”
BackgroundA spatial sequencing atlas of age-induced changes in the lung during influenza infection
Kasmani, M. Y., Topchyan, P., Brown, A. K., Brown, R. J., Wu, X., Chen, Y., Khatun, A., Alson, D., Wu, Y., Burns, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42021-y · Cited by 61
Khurana, S., Coyle, E. M., Dimitrova, M., Castellino, F., Nicholson, K. G., Giudice, G. D., & Golding, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095496 · Cited by 52
“Heterologous Prime-boost Vaccination Elicits Higher Affinity Antibodies against HA1 (but not HA2) Compared with Antibodies from Unprimed Individuals We have previously demonstrated that it is possible to measure the avidity of antibodies in the polyclonal human sera by measurements of steady state binding dissociation…”
BackgroundSelf-citationAging, cytomegalovirus (CMV) and influenza vaccine responses
Frasca, D., & Blomberg, B. B. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1105413 · Cited by 46
Self-citationAge effects on mouse and human B cells
Blomberg, B. B., & Frasca, D. (2013) · Immunologic Research · doi:10.1007/s12026-013-8440-9 · Cited by 46
“In collaboration with Hana Golding’s laboratory, we have shown that AID correlates with higher affinity antibodies to the vaccine [69].”
Self-citationHalliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45
“The activated MBCs may have differentiated directly into ASCs or entered germinal centers for additional rounds of affinity maturation before ASC formation [32].”
BackgroundSelf-citationCellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Ageing and obesity similarly impair antibody responses
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12824 · Cited by 47
Self-citationImpact of stress on aged immune system compartments: Overview from fundamental to clinical data
Fali, T., Vallet, H., & Sauce, D. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.02.007 · Cited by 48
“This leads to impaired production of higher affinity protective antibody (Khurana et al., 2012).”
BackgroundAge‐related factors that affect B cell responses to vaccination in mice and humans
Frasca, D., Blomberg, B. B., Garcia, D., Keilich, S. R., & Haynes, L. (2020) · Immunological Reviews · doi:10.1111/imr.12864 · Cited by 47
Self-citationFrasca, D., Romero, M., Diaz, A., Garcia, D., Thaller, S. R., & Blomberg, B. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041839 · Cited by 47
Self-citationMemory B cells form in aged mice despite impaired affinity maturation and germinal center kinetics
Goenka, R., Scholz, J. L., Naradikian, M. S., & Cancro, M. P. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.013 · Cited by 38
“…class switch recombination are significantly reduced in aged mice and humans (Frasca et al., 2011; Frasca et al., 2004), and this is associated with affinity maturation and vaccine responses in elderly humans (Ademokun et al., 2011; Frasca et al., 2011; Frasca et al., 2010; Khurana et al., 2012).”
BackgroundProfiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers
Jacobson, R. M., Grill, D. E., Oberg, A. L., Tosh, P. K., Ovsyannikova, I. G., & Poland, G. A. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011990 · Cited by 43
“The polyclonal affinity of antibodies has also been shown to play a role in age-specific antibody responses following influenza vaccination.(15) As more investigators include B-cell ELISPOT in their assessment of humoral Figure 2.”
BackgroundCagigi, A., Rinaldi, S., Martino, A. D., Manno, E. C., Zangari, P., Aquilani, A., Cotugno, N., Nicolosi, L., Villani, A., Bernardi, S., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.003 · Cited by 34
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity
Cagigi, A., Rinaldi, S., Cotugno, N., Manno, E. C., Santilli, V., Mora, N., Zangari, P., Aquilani, A., Tchidjou, H. K., Giaquinto, C., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000144 · Cited by 31
Palma, P., Rinaldi, S., Cotugno, N., Santilli, V., Pahwa, S. G., Rossi, P., & Cagigi, A. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28698 · Cited by 30
An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly
Bell, M. R., & Kutzler, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114175 · Cited by 29
van Twillert, I., den Brink, J. A. M. V. G.-V., Poelen, M. C. M., Helm, K., Kuipers, B., Schipper, M., Boog, C. J. P., Verheij, T. J., Versteegh, F. G. A., & van Els, C. A. C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085227 · Cited by 29
“Blomberg and coworkers showed that elderly have a reduced ability to generate high affinity antibodies and IgG1 and IgG3 responses against influenza A hemagglutinin [68,69].”
BackgroundWaning and aging of cellular immunity toB. pertussis
van Twillert, I., Han, W. G. H., & van Els, C. A. C. M. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv071 · Cited by 37
“The ability to generate high-affinity antibodies and IgG1 and IgG3 responses is reduced in elderly, as was shown for influenza A hemagglutinin antibody responses (Khurana et al. 2012; Frasca et al. 2013).”
BackgroundLi, H., & Pauza, C. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201444911 · Cited by 36
Davydov, A. N., Obraztsova, A., Lebedin, M. Y., Turchaninova, M. A., Staroverov, D. B., Merzlyak, E. M., Sharonov, G. V., Кладова, О. В., Shugay, M., Britanova, O. V., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02309 · Cited by 31
“Of note, it was earlier demonstrated that AID levels and intensity of hypermutation decrease with aging, but only after the age of 60 (63, 69, 70)—beyond the age of the cohorts that we have studied in the current work.”
BackgroundB and T Cell Immunity in Tissues and Across the Ages
Booth, J. S., & Toapanta, F. R. (2021) · Vaccines · doi:10.3390/vaccines9010024 · Cited by 39
“Furthermore, a decline in AID mRNA in human B cells correlates with decreased antibody affinity maturation following influenza vaccination has been reported [205].”
BackgroundLuo, Y., Zhang, X., Chen, R., Li, R., Liu, Y., Zhang, J., Liu, Q., Si, M., Liu, J., Wu, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00858-z · Cited by 29
“In human immunized influenza H1N1 vaccination, AID activity in B cells is closely correlated with polyclonal antibody affinity maturation.(8) To increase the humoral immune response to the vaccine, it is reasonable to increase the proper expression or activity of AID during antigen immunization.”
BackgroundKhurana, S., Coyle, E. M., Manischewitz, J. F., King, L. R., Ishioka, G. Y., Alexander, J., Smith, J., Gurwith, M., & Golding, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115476 · Cited by 25
“We have previously demonstrated that it is possible to measure the avidity of antibodies in the polyclonal human sera by measurements of steady-state binding dissociation rates of antigenantibody complexes using the SPR technology [4, 7, 10, 12, 13].”
MethodSelf-citationJung, J., Mundle, S. T., Ustyugova, I. V., Horton, A. P., Boutz, D. R., Pougatcheva, S. O., Prabakaran, P., McDaniel, J. R., King, G. R., Park, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148763 · Cited by 22
Tang, J., Grubbs, G., Lee, Y., Huang, C., Ravichandran, S., Forgacs, D., Golding, H., Ross, T. M., & Khurana, S. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103748 · Cited by 21
“males against H1N1pdm09 hemagglutinin, even though the post-vaccination HAI titers were similar between the sexes[42].”
Self-citationTete, S. M., Krammer, F., Lartey, S. L., Bredholt, G., Wood, J., Skrede, S., & Cox, R. J. (2016) · npj Vaccines · doi:10.1038/npjvaccines.2016.1 · Cited by 22
“The higher avidity of stalk-specific antibodies could be explained by antibody secreting cells producing these antibodies being derivatives of memory B cells from previous H1N1 encounters that have gone through several rounds of selection and affinity maturation.(25,26)As the 2009 pandemic H1N1 contained a novel head,…”
BackgroundSeeking Help: B Cells Adapting to Flu Variability
der Most, R. G. V., Roman, F. P., Innis, B. L., Hanon, E., Vaughn, D. W., Gillard, P. H., Walravens, K., & Wettendorff, M. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008409 · Cited by 20
Influenza vaccine response: future perspectives
Mameli, C., D’Auria, E., Erba, P., Nannini, P., & Zuccotti, G. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1391786 · Cited by 18
“after H1N1pdm09 vaccination directly correlate with an increase in polyclonal antibody affinity [19].”
BackgroundКостинов, М. П., Ахматова, Н. К., Khromova, E. A., Skhodova, S. A., Stolpnikova, V. N., Cherdantsev, A. P., & Vlasenko, A. E. (2018) · InTech eBooks · doi:10.5772/intechopen.77006 · Cited by 18
Perspectives on vaccine development for the elderly
Oviedo‐Orta, E., Li, C. K.-F., & Rappuoli, R. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.008 · Cited by 15
“In vaccination response to pandemic H1N1 vaccine, the elderly have a minimal increase in antibody affinity whereas younger population shows affinity maturation and this is consistent with the activity of activation-Induced cytidine deaminase [24].”
Older Human B Cells and Antibodies
Dunn‐Walters, D. K., & O’Hare, J. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_21-1 · Cited by 20
Antibody Responsiveness to Influenza: What Drives It?
Lin, X., Lin, F., Liang, T., Ducatez, M., Zanin, M., & Wong, S. (2021) · Viruses · doi:10.3390/v13071400 · Cited by 16
The Problem of Antigen Affinity Discrimination in B-Cell Immunology
Raychaudhuri, S. (2013) · ISRN Biomathematics · doi:10.1155/2013/845918 · Cited by 11
Song, Y., Wang, J., Yang, Z., He, Q., Bao, C., Xie, Y., Sun, Y., Li, S., Quan, Y., Yang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1406138 · Cited by 15
Crofts, K. F., Holbrook, B. C., D’Agostino, R. B., & Alexander‐Miller, M. A. (2022) · Vaccines · doi:10.3390/vaccines10040494 · Cited by 8
“A study of young and elderly adults showed that the level of AID after vaccination correlated with the fold increase in antibody affinity to HA [46].”
BackgroundFrasca, D., & Blomberg, B. B. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017020113 · Cited by 6
Self-citationFrasca, D., Diaz, A., & Blomberg, B. B. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2963-4_9 · Cited by 5
Self-citationSevere pleuritis and pericarditis associated with very‐late‐onset systemic lupus erythematosus
Ikushima, H., Mitsutake, A., Hideyama, T., Sato, T., Katsumata, J., Seki, T., Maekawa, R., Kishida, Y., & Shiio, Y. (2018) · Journal of General and Family Medicine · doi:10.1002/jgf2.157 · Cited by 4
Sex and the Aging Immune System
Gibson, D. C., & Bupp, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00059-2 · Cited by 2
Influenza Vaccination in Older Adults
McElhaney, J. E., & Frasca, D. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_69
Self-citationInfluenza Vaccination in Older Adults
McElhaney, J. E., & Frasca, D. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_69-1
Self-citationVACCINATION EFFECTIVENESS IN THE POPULATION OF THE ELDERLY PEOPLE AND THE AGING OF THE IMMUNE SYSTEM
Zuziak, P., Przeorski, K., Dereziński, M. M., Mendowski, M., & Kliniec, K. (2022) · Postepy Biologii Komorki · doi:10.59674/pbk3
Wraith, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00134-4
Vallet, H., Guidet, B., Boumendil, A., de Lange, D. W., Leaver, S. K., Szczeklik, W., Jung, C., Sviri, S., Beil, M., & Flaatten, H. (2023) · Figshare · doi:10.6084/m9.figshare.23884436
Respiratory virus immune response in the aged host
Parks, O. B., Kalavacharla, A., & Williams, J. V. (2026) · Immunity & Ageing · doi:10.1186/s12979-026-00559-7
“Studies from Frasca and Blomberg also showed that upon administration of the influenza vaccine to older humans there was an impaired vaccine-specific antibody response (140–142).”
Influenza vaccine-specific CD4+ T cell responses are impaired in older adults
Saint-Charles, P., Hagen, M., Autaa, G., Bijvank, E., Beckers, L., van Beek, J., van Baarle, D., Weinberger, B., & Appay, V. (2026) · npj Vaccines · doi:10.1038/s41541-026-01437-5 · Cited by 1
Miller, K., Gelsomini, A., Romero, M., Garcia, D., Diaz, A., Bueno, V., Hansen, J., Jurecic, R., Antoni, M. H., & Frasca, D. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1944615
Self-citation
Metadata
- Authors
- Khurana, S., Frasca, D., Blomberg, B., & Golding, H.
- Affiliations
- Center for Biologics Evaluation and Research (US)
- University of Miami (US)
- Corresponding author
- Khurana, Surender
- Golding, Hana
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-13
- Volume
- 8
- Issue
- 9
- Pages
- e1002920
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3441753
- OpenAlex
- W2060680095
- Cited by
- 85
- References
- 34
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 11 · 2016: 5 · 2015: 9 · 2014: 9 · 2013: 10
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (AG023717, AG032576)
- National Institute on Aging (R01AG032576, R37AG023717, R01AG023717, AG 023717, R56AG032576, AG032576)
- National Institute of Allergy and Infectious Diseases (R21AI096446)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- activation-induced cytidine deaminase, AID, B cells, influenza hemagglutinin, age-related antibody response, somatic hypermutation
- MeSH terms
- AICDA (Activation-Induced Cytidine Deaminase), Adult, Age Factors, Aged, Aged, 80 and over, Antibodies, Viral, Antibody Affinity, B-Lymphocytes, Cytidine Deaminase, Female, Hemagglutination Inhibition Tests, Humans, Influenza, Human, Influenza Vaccines, Male, Middle Aged, Vaccination, Hemagglutinin Glycoproteins, Influenza Virus, Influenza A Virus, H1N1 Subtype, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.